Litcius/Paper detail

Clinical and pathological features of breast cancer patients eligible for adjuvant abemaciclib

Paolo Tarantino, Qingchun Jin, Elizabeth A. Mittendorf, Tari A. King, Giuseppe Curigliano, Sara M. Tolaney

2022Annals of Oncology18 citationsDOIOpen Access PDF

Topics & Concepts

MedicineOncologyBreast cancerPathologicalInternal medicineAdjuvantCancerAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchLung Cancer Research Studies
Clinical and pathological features of breast cancer patients eligible for adjuvant abemaciclib | Litcius